Fundraising Fox

Spruce Biosciences

NASDAQ: SPRB

South San Francisco, US · Founded 2016 · Delaware corporation · 6 known investors

sprucebiosciences.com ↗
Biotechin /spruce-biosciences@spruce_bio

Founders & leadership

JS
Javier SzwarcbergExecutive Officer, Director
SG
Samir GharibExecutive Officer
RK
RICHARD KINGExecutive Officer, Director
CS
CAMILLA SIMPSONDirector
SC
Simpson CamillaDirector
TA
Tiba AynechiDirector
BM
Bali MuralidharDirector
NO
NIALL O'DONNELLDirector
JH
JONAS HANSSONDirector
DC
DINA CHAYADirector
KW
Kirk WaysDirector
PB
Percival Barretto-KoDirector

Investors · 6

Aisling CapitalNew York
HealthCapStockholm
RiverVest Venture PartnersSt. Louis · $500K – $3M
AbingworthreportedLondon · $15M – $30Mvia Bali Muralidhar · board
Norwest Venture PartnersreportedMenlo Park · $10M – $30Mvia Tiba Aynechi · board
OrbiMedreportedNew York · $1M – $75Mvia Dina Chaya · board

Reported raises · per SEC filings

Form D private placements
▶$50MraisedOct 2025 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Kirk WaysDirector
  • Javier SzwarcbergExecutive Officer, Director
  • Simpson CamillaDirector
  • Percival Barretto-KoDirector
  • Tiba AynechiDirector
  • Samir GharibExecutive Officer
  • Bali MuralidharDirector
  • Michael GreyExecutive Officer, Director
  • Daniel SpiegelmanDirector
Offering amount
$50M
Amount sold
$50M
Sales commissions
$3M
Placement agents
Citizens JMP Securities, LLC, H.C. Wainwright & Co., LLC, Leerink Partners LLC
First sale
Oct 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$53.6MraisedFeb 2023 · 20 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel SpiegelmanDirector
  • Javier SzwarcbergExecutive Officer, Director
  • Dina ChayaDirector
  • Tiba AynechiDirector
  • Samir GharibExecutive Officer
  • Kirk WaysDirector
  • Simpson CamillaDirector
  • Bali MuralidharDirector
  • Ralph William Charlton IIIExecutive Officer
  • Michael GreyExecutive Officer, Director
Offering amount
$53.6M
Amount sold
$53.6M
Sales commissions
$2.4M
Placement agents
SVB Securities LLC
First sale
Feb 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$88MraisedAug 2020 · 11 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • SAMIR GHARIBExecutive Officer
  • RICHARD KINGExecutive Officer, Director
  • TIBA AYNECHIDirector
  • CAMILLA SIMPSONDirector
  • NIALL O'DONNELLDirector
  • JONAS HANSSONDirector
  • BALI MURALIDHARDirector
  • MICHAEL GREYDirector
  • DINA CHAYADirector
Offering amount
$88M
Amount sold
$88M
First sale
Feb 2020
Incorporated
Corporation, Delaware, 2016
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.